Onset of multiple sclerosis associated with anti-TNF therapy

被引：232

作者：

Sicotte, NL ^{[1
]}

Voskuhl, RR ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Sch Med, Dept Neurol, Div Brain Mapping, Los Angeles, CA USA

来源：

NEUROLOGY | 2001年 / 57卷 / 10期

关键词：

D O I：

10.1212/WNL.57.10.1885

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Therapies aimed at inhibiting tumor necrosis factor (TNF) a proinflammatory cytokine implicated in autoimmune disease are effective, especially for rheumatoid arthritis. We report a patient with new onset MS closely associated with the initiation of anti-TNF therapy for juvenile rheumatoid arthritis. It is possible that the inhibition of TNF triggered MS in this individual.

引用

页码：1885 / 1888

页数：4

共 11 条

[1] TNF neutralization in MS - Results of a randomized, placebo-controlled multicenter study [J].

Arnason, BGW ;

Jacobs, G ;

Hanlon, M ;

Clay, BH ;

Noronha, ABC ;

Auty, A ;

Davis, B ;

Nath, A ;

Bouchard, JP ;

Belanger, C ;

Gosselin, F ;

Thibault, M ;

Duquette, P ;

Bourgoin, P ;

DuBois, R ;

Girard, M ;

Ebers, GC ;

Rice, GPA ;

Vandervoort, MK ;

Francis, GS ;

Duncan, L ;

Lapierre, Y ;

Freedman, MS ;

Christie, SN ;

Rabinovitch, HE ;

Patry, D ;

Murphy, WF ;

Peters, S ;

McGuiness, SD ;

Murray, TJ ;

Bhan, V ;

Maxner, CE ;

Van Dorpe, R ;

Oger, JJ ;

Nelson, J ;

Morrison, W ;

Bogle, N ;

Beall, S ;

Vorobeychick, G ;

Hiltbrunner, AV ;

Bock, J ;

Habil ;

Lesslauer, W ;

Li, DKB ;

Paty, DW ;

Zhao, GJ .

NEUROLOGY, 1999, 53 (03) :457-465

[2] Soluble cytokine receptors: novel immunotherapeutic agents [J].

Fernandez-Botran, R .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (03) :497-514

[3]

Hohlfeld R, 1996, Mult Scler, V1, P376

[4] LYMPHOTOXIN AND TUMOR NECROSIS FACTOR-ALPHA PRODUCTION BY MYELIN BASIC PROTEIN-SPECIFIC T-CELL CLONES CORRELATES WITH ENCEPHALITOGENICITY [J].

POWELL, MB ;

MITCHELL, D ;

LEDERMAN, J ;

BUCKMEIER, J ;

ZAMVIL, SS ;

GRAHAM, M ;

RUDDLE, NH ;

STEINMAN, L .

INTERNATIONAL IMMUNOLOGY, 1990, 2 (06) :539-544

[5]

Raza A, 2000, MICROSC RES TECHNIQ, V50, P229, DOI 10.1002/1097-0029(20000801)50:3<229::AID-JEMT6>3.0.CO

[6]

2-H

[7] Fas(t) track to apoptosis in MS -: TNF receptors may suppress or potentiate CNS demyelination [J].

Segal, BM ;

Cross, AH .

NEUROLOGY, 2000, 55 (07) :906-907

[8] IDENTIFICATION OF LYMPHOTOXIN AND TUMOR-NECROSIS-FACTOR IN MULTIPLE-SCLEROSIS LESIONS [J].

SELMAJ, K ;

RAINE, CS ;

CANNELLA, B ;

BROSNAN, CF .

JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) :949-954

[9] EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS - IMMUNOTHERAPY WITH ANTITUMOR NECROSIS FACTOR ANTIBODIES AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS [J].

SELMAJ, KW ;

RAINE, CS .

NEUROLOGY, 1995, 45 (06) :S44-S49

[10] Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 [J].

vanOosten, BW ;

Barkhof, F ;

Truyen, L ;

Boringa, JB ;

Bertelsmann, FW ;

vonBlomberg, BME ;

Woody, JN ;

Hartung, HP ;

Polman, CH .

NEUROLOGY, 1996, 47 (06) :1531-1534

← 1 2 →